From יוסי אבו, מנכ”ל NewMed Energy, משק הגז הטבעי – ישראל והזירה האזורית · · Bizportal ביזפורטל
“We received approval for a development plan and signed a very significant agreement for 130 BCM, $3.5 billion, the goal of which is to bring us to an investment decision for Leviathan Phase 2 in the fourth quarter of this year. We are looking at October-November to receive the investment decision, a very significant decision that should bring a lot of value for us in Leviathan.”
On , Yossi Abu, CEO at NewMed Energy, spoke about investment decision during יוסי אבו, מנכ”ל NewMed Energy, משק הגז הטבעי – ישראל והזירה האזורית on Bizportal ביזפורטל.
Yossi Abu, CEO of NewMed Energy, has been active in investor calls and industry conferences discussing the company's financial results and strategic plans. In early 2023, he reported record quarterly production and earnings, including a net profit of $121 million for the first quarter. Abu stated that the company paid $280 million of a $500 million bond early and announced a $15 million dividend. He also discussed a non-binding offer from BP and ADNOC, saying the company is working on due diligence, an independent committee assessment, and shareholder agreements, with a target of eight weeks to finalize a shareholder agreement and two to three months for regulatory approval. Abu has emphasized the company's focus on expanding its natural gas operations. He said NewMed is working to increase Leviathan production capacity to 14 BCM per year by mid-2025 and is evaluating a floating LNG project, for which partners approved a $100 million budget. He also noted the company is appraising the A3 well in the Aphrodite field, aiming to develop it using existing infrastructure in Cyprus. At an energy conference, Abu stated that the company is working to double Leviathan volumes to 24 BCM and is exploring pipeline options to Egypt. In Morocco, he said NewMed is interested in natural gas, renewables, and hydrogen, adding that the country has the potential to become a global energy hub.